Esperion Therapeutics
Ann Arbor, Michigan, United States · Biotechnology, Health Care, Pharmaceutical
Esperion Therapeutics is a pharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative medicines for patients at risk for cardiovascular and cardiometabolic diseases.
Key facts
- Headquarters
- Ann Arbor, Michigan, United States
- Employees
- 310
- Industries
- Biotechnology, Health Care, Pharmaceutical
- Website
- esperion.com
- Company page
Recent activity at Esperion Therapeutics
Leadership
- Sheldon Koenig, President and CEO of Esperion Therapeutics
- Betty Swartz, Chief Business Strategy Officer (CBO)
- John Harlow, Chief Commercial Officer
Verified email and direct lines for Esperion Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Esperion Therapeutics files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to Esperion Therapeutics
- Santhera Pharmaceuticals · Biotechnology, Health Care, Pharmaceutical, pharmaceuticals, Therapeutics
- Kenox Pharmaceuticals · Biotechnology, Health Care, Pharmaceutical, pharmaceuticals, Therapeutics
- Bicycle Therapeutics · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- ABC Pharmaceuticals · Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Nurix Therapeutics · Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Esperion Therapeutics: questions and answers
What does Esperion Therapeutics do?
Esperion Therapeutics is a pharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative medicines for patients at risk for cardiovascular and cardiometabolic diseases.
Where is Esperion Therapeutics headquartered?
Esperion Therapeutics is headquartered in Ann Arbor, Michigan, United States.
How many employees does Esperion Therapeutics have?
Esperion Therapeutics has about 310 employees.
Who leads Esperion Therapeutics?
Sheldon Koenig is a President and CEO of Esperion Therapeutics at Esperion Therapeutics.
What is the latest news on Esperion Therapeutics?
On Mar 03, 2026, Esperion Therapeutics Announces Acquisition of Corstasis Therapeutics
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy